PHEMS’ Post

🌟 Exciting News from SYNTHEMA! 🌟 This past Friday, 19th April, SYNTHEMA was thrilled to host the second meeting for the sister projects funded under the HORIZON-HLTH-2022-IND-13-02 call. The team is now preparing to launch a synergetic and coordinated effort to deliver more impact and increase awareness about the technologies employed and results achieved by each project. First step? Name, branding, colors! To make this recognizable across channels and networks. 🚀 Breaking Down Data Silos Our mission is clear: leverage cutting-edge technologies, we aim to enhance healthcare services and make significant strides towards more accessible and efficient patient care. 🤝 A Heartfelt Thank You We extend our deepest gratitude to all the projects that participated in this landmark event: EMERALDS NearData Consortium Phase4AI-EUProject SECURED EU project FLUTE Project - AI & Prostate Cancer PHEMS AISym4MED - Horizon Europe Your contributions and commitment to this cause are invaluable. We eagerly look forward to the advancements we will achieve together and the impact we will have on healthcare worldwide. #HealthcareInnovation #EuropeanCommission #AI #FederatedLearning #HealthcareTechnology #Collaboration #FutureOfHealthcare #horizoneurope

🌟 Exciting News from SYNTHEMA! 🌟 This past Friday, 23rd February, SYNTHEMA was thrilled to host the inaugural meeting between sister projects under the HORIZON-HLTH-2022-IND-13-02 call. This gathering marked a significant milestone, bringing together initiatives funded by the European Commission, each dedicated to revolutionizing healthcare through advanced technologies such as AI and federated learning. 🚀 Breaking Down Data Silos Our mission is clear: leverage cutting-edge technologies, we aim to enhance healthcare services and make significant strides towards more accessible and efficient patient care. This first meeting was not just a formal gathering; it was the beginning of a promising collaboration aimed at amplifying awareness about these critical topics. Together, we are committed to keeping the population informed about our projects and the tangible results we aim to achieve. 🤝 A Heartfelt Thank You We extend our deepest gratitude to all the projects that participated in this landmark event: EMERALDS NearData Consortium Phase4AI-EUProject SECURED EU project FLUTE Project - AI & Prostate Cancer PHEMS AISym4MED - Horizon Europe Your contributions and commitment to this cause are invaluable. We eagerly look forward to the advancements we will achieve together and the impact we will have on healthcare worldwide. #HealthcareInnovation #EuropeanCommission #AI #FederatedLearning #HealthcareTechnology #Collaboration #FutureOfHealthcare #horizoneurope

Introducing the #S3EStart Research Projects 🌟 OncoMets 🦾 The solution: An in vitro diagnostic tool for #BreastCancer monitoring, driven by a ground-breaking circulating biomarker discovery platform. Unlike invasive tumour biopsy and radiation-based methods, ONCOSECRET will provide accurate, non-invasive, real-time monitoring, enabling #EarlyDetection and reducing mortality rates. Easily integrated into #HealthcareSystems, it will empower #Oncologists to combat breast cancer effectively. 🧑🔬 The research team: Ana Sofia Ribeiro, Joana Paredes, Rita Pereira de Carvalho, Inês Sousa Conde, Bruno Freitas and Bárbara Macedo. 🔬 The institutions involved: i3S - Instituto de Investigação e Inovação em Saúde OncoMets is one of the 14 projects selected to participate in the 2024 edition of S3E Start, the EU-funded program fostering deep tech research and entrepreneurship in Southern Europe. It’s led by HiSeedTech, funded by European Innovation Council and SMEs Executive Agency (EISMEA) and officially recognised by EIT Deep Tech Talent. 🤝 This team is being supported by S3E Start mentors António Dinis. Don't forget to join us for the Start Open Day! Access the livestream on 18 June and watch all the teams present their science-based tech projects live from Lisbon 🚀 https://lnkd.in/ec5yyMzY #EUfunded #DeepTech #DeepTechInnovation #FromLabToMarket #HealthTech #HealthcareInnovation

Yesterday, ONCOSCREEN participated in the first meeting of "Prevention, including Screening” and "Understanding" of the #EU Mission Cancer clusters. The LUCIA EU Project hosted the meeting in San Sebastián and 🌐 online. After a presentation from the European Health and Digital Executive Agency (HaDEA) representative, Marianne Da Silva, all projects were introduced. Anax Fotopoulos (EXUS AI LABS) presented #ONCOSCREEN to participants. The meeting also included envigorating discussions on the future collaborative opportunities for advancing #CancerResearch, including such topics as: ▫ Research and innovation updates ▫ Data management ▫ Citizen engagement ▫ Communication and dissemination strategy 👏 Many thanks to the team of LUCIA EU Project for a great start to the annual cluster meetings. #HorizonEurope #EUCancerMission #CancerPlan #CancerResearch #Clustering #CancerAwareness #ColorectalCancer

Cancer is a scary word. Unfortunetely we're hearing the word more often. From friends, friends of friends, family and in the workplace. Globally an estimated 20 million new cases and 9.7 million deaths were reported in 2022 alone. At AIXCS, healthcare is one of core investment areas for us and it was a pleasure to see the recent successful seed funding round at a French start-up Spotlight Medical, leveraging AI to provide faster diagnosis and more effective individualized treatment. This would be a game-changer because not all treatments are created equal, and what works for one person might not work for another. By using AI to analyze mountains of patient data, Spotlight Medical can ensure that no one is over or undertreated, giving everyone the best chance at beating cancer. Read the full story at https://lnkd.in/dRmn2xYp To learn more about AIXCS, and join our venture pre-IPO whitelist visit https://www.aixcs.ai #AI #biotech #cancer #venturecapital #impact

In our current series, we are introducing our project's public deliverables - their aim, impact, and the future steps they are the building blocks of. 💡 EOSC4Cancer's Deliverable 2.1 gives an overview of the Standard Operating Procedures (SOPs) for the key datasets in EOSC4Cancer, and describes what steps would be appropriate to improve these SOPs. This deliverable is authored by Work Package 2 partners EMBL, Lygature, Barcelona Supercomputing Center, and Erasmus MC. They are collaborating towards developing data harmonization efforts to make cancer research more reproducible across all Member States. Read more about the deliverable here: emp.onl/sXFGl #FAIRdata #cancerdata #datasharing

🔬 Exciting News Alert! 🚀 Rosetta Omics, a cutting-edge deeptech startup revolutionizing oncology precision medicine, is thrilled to announce its membership and partnership with France Biotech At Rosetta Omics, our mission is clear: to leverage the power of AI and multiomics data to drive advancements in cancer treatment. With this new partnership with France Biotech, a leading voice in the French biotech ecosystem, we're poised to accelerate our impact and forge invaluable connections within the french healthcare industry. Joining France Biotech opens up a world of opportunities for collaboration, innovation, and growth. We're eager to collaborate with fellow trailblazers, access resources, and contribute to the vibrant biotech community in France and beyond. Our journey to transform oncology is fueled by a passionate team dedicated to making a difference in the lives of patients worldwide. Together with France Biotech, we're committed to driving forward the future of healthcare through groundbreaking research, technology, and partnerships. #RosettaOmics #FranceBiotech #Oncology #PrecisionMedicine #Biotech #Innovation #AI #multiomics #HealthcareRevolution 🧬💡

This is a great example of AI in healthcare. So inspiring to see the amazing work being done in this space and it will no doubt have profound impact on how we prevent, diagnose and treat disease. It's never been a greater time to be a tech investor. Subscribe to our LinkedIn page (below) to follow AI solutions (and opportunities) in healthcare, sustainability, cybersecurity and more. #aiforgood

Cure51's mission is to bring hope to every patient suffering from Cancer. To turn that vision into a reality, the gathering of a cohesive and experienced team of scientists, experts and passionate people is the first major step ! Only incredible talents can help us to win that battle against one of the most aggressive diseases of the century. Our Talents all have in common the strong belief that our ultimate ambition to kill cancer can soon be a reality. From biocomputation to Data engineering, from biological sample analysis to Tech & infrastructure, from Operations to Product – they are all driven by the same passion: curing Cancer. More than 10 nationalities are already part of this superb team! We proudly proclaim that "Talents are in our DNA." #oncology #career #hopeisforeveryone #diversity #cancerresearch #biotechnology #talents #techbio

Continuing to take small steps towards big goals, Histofy partnership with LUMIARES (a Belgian health tech VC fund) marks a new chapter in the Histofy story. Together with the Lumaires partners' wealth of knowledge, expertise and experience of pathology, oncology and medtech industry, we continue the march of our organic growth towards delivering world-class AI solutions for improved patient outcomes and accelerated biomarker discovery #AI #SmallSteps #BigGoals